| Gujarat Terce Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524314 |
NSE Symbol : - |
P/E(TTM) : 13.03 |
|
ISIN Demat : INE499G01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.15 |
|
Book Value(₹) : 12.49 |
Market Cap(₹Cr) : 31.98 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 11.40 | 12.29 | 12.93 | 10.85 | 12.32 | 12.68 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 11.40 | 12.29 | 12.93 | 10.85 | 12.32 | 12.68 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.08 | 0.13 | 0.05 | 0.09 | 0.09 | 0.07 |
| Total Income | 11.48 | 12.42 | 12.98 | 10.95 | 12.41 | 12.75 |
| Total Expenditure | 11.11 | 11.16 | 11.04 | 10.87 | 11.27 | 11.59 |
| PBIDT | 0.36 | 1.26 | 1.94 | 0.07 | 1.14 | 1.16 |
| Interest | 0.03 | 0.04 | 0.07 | 0.05 | 0.07 | 0.08 |
| PBDT | 0.34 | 1.22 | 1.88 | 0.03 | 1.07 | 1.07 |
| Depreciation | 0.13 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
| Tax | 0.31 | 0.34 | 0.44 | 0.00 | 3.58 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.21 | 0.03 | -0.06 | -0.03 | 0.78 | -0.03 |
| Reported Profit After Tax | 0.10 | 0.76 | 1.40 | -0.04 | -3.39 | 1.01 |
| Extra-ordinary Items | -0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.24 | 0.76 | 1.40 | -0.04 | -3.39 | 1.01 |
| EPS (Unit Curr.) | 0.13 | 0.95 | 1.89 | -0.06 | -4.57 | 1.36 |
| EPS (Adj) (Unit Curr.) | 0.13 | 0.95 | 1.89 | -0.06 | -4.57 | 1.36 |
| Calculated EPS (Unit Curr.) | 0.13 | 0.98 | 1.89 | -0.06 | -4.57 | 1.36 |
| Calculated EPS (Adj) (Unit Curr.) | 0.13 | 0.98 | 1.89 | -0.06 | -4.57 | 1.36 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.52 | 3.91 | 7.56 | -0.23 | -18.28 | 5.43 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.52 | 3.91 | 7.56 | -0.23 | -18.28 | 5.43 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 7.79 | 7.79 | 7.42 | 7.42 | 7.42 | 7.42 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 3.16 | 10.25 | 15.00 | 0.65 | 9.25 | 9.15 |
| PBDTM(%) | 2.98 | 9.93 | 14.54 | 0.28 | 8.69 | 8.44 |
| PATM(%) | 0.88 | 6.18 | 10.83 | -0.37 | -27.52 | 7.97 |
